Sacco Christine 4
4 · Prestige Consumer Healthcare Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Sacco Christine
CFO & COO
Transactions
- Sale
Common Stock, par value $0.01 per share
2024-02-14$68.08/sh−5,231$356,126→ 24,738 total - Exercise/Conversion
Employee Stock Options (rights to buy)
2024-02-14−24,788→ 0 totalExercise: $29.46Exp: 2028-05-07→ Common Stock (24,788 underlying) - Exercise/Conversion
Common Stock, par value $0.01 per share
2024-02-14$29.46/sh+24,788$730,254→ 46,526 total - Sale
Common Stock, par value $0.01 per share
2024-02-14$68.41/sh−24,788$1,695,747→ 21,738 total
Footnotes (2)
- [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $67.74 to $68.41.
- [F2]The options vested in three installments of 8,262 shares on May 7, 2019 and 8,263 shares each on May 7, 2020 and May 7, 2021.